Viggiano Domenico, De Filippo Gianpaolo, Rendina Domenico, Fasolino Antonio, D'Alessio Norma, Avellino Natalia, Verga Maria Carmela, Prisco Antonio Giosué, Sorrentino Felice Antonio, Sabatini Paola, Chiarelli Francesco
Primary Care Pediatrics, ASL Salerno, Italy.
J Pediatr Gastroenterol Nutr. 2009 Sep;49(3):329-34. doi: 10.1097/MPG.0b013e31819b54b7.
To determine the prevalence of metabolic syndrome (MS) in a primary care pediatric setting and to collect clinical and biochemical data, allowing for a prediction of its presence in a supposedly healthy population.
Belonging to a pediatric population followed by pediatricians of the Italian National Health Service, 415 subjects with obesity as a unique selection criterion were enrolled. The entire cohort was screened for MS, which was defined as the presence of at least 2 other findings out of obesity: fasting hyperglycemia, low levels of high-density lipoproteins cholesterol, hypertriglyceridemia, and hypertension.
The overall prevalence of MS was 30.8%. Major findings (out of obesity) were low high-density lipoproteins cholesterol levels (46.2%), hypertension (23.6%), hypertriglyceridemia (22.2%), and fasting hyperglycemia (16.6%). Waist-to-height ratio was the only clinical parameter directly related to MS, with the same predictive power of insulin resistance.
Metabolic syndrome can be present in a significant percentage of "healthy" obese children, and a simple clinical parameter could identify at-risk subjects. This observation justifies the development and implementation of pediatric networks for obesity screening programs.